Market Crash 2020: Will Bombardier (TSX:BBD.B) Survive?

With shares down to just $0.40 each, Bombardier Inc. (TSX:BBD.B) has excellent upside potential. But can it emerge from a crushing debt without bankruptcy?

| More on:
Aircraft wing plane

Image source: Getty Images

The last few years haven’t been great for Bombardier (TSX:BBD.B), and that was before COVID-19 wrecked the economy.

The company placed all its eggs in the CSeries basket, confident its revolutionary new plane would rescue it from all its financial woes. The CSeries did sell pretty well, but Bombardier was forced to sell the entire program to aviation giant Airbus at a discounted price.

Another big issue that has plagued Bombardier for years has been its bloated balance sheet. Even after embarking on a program that saw many non-core assets sold in 2019, Bombardier’s debt is still quite high. At the end of 2019, the company had US$9.3 billion in long-term debt, although that was offset by some US$3 billion in cash.

Finally, 2019 wasn’t a great year for Bombardier’s transportation business. The train division has traditionally been Bombardier’s crown jewel, but it suffered from bloated costs, disappointing earnings, and losing sales to competitors. Plenty of stimulus money is sloshing around today, but cities are looking to simply keep things open. Nobody has immediate plans to expand public rail networks or subways.

All this combined to put big pressure on Bombardier’s share price from 2014 to 2019. And then COVID-19 decimated the economy in 2020, taking the stock down another level. As I type this, shares trade at just $0.40 each.

Is bankruptcy in the cards, or will the company find a way out of this mess? Let’s take a closer look.

Is Bombardier doomed?

Perhaps the biggest issue for investors who are looking to speculate on dirt-cheap Bombardier shares is, there’s a really compelling argument the company would be better off in bankruptcy.

Look at it this way: in 2019, Bombardier paid US$670 million in interest. Add in preferred share dividends, and the number approaches US$700 million. That’s a lot of money for any company, especially one like Bombardier that is consistently non-profitable.

Not all of Bombardier’s debt would be discharged in a bankruptcy, since some of it is secured by real estate. And remember, the company does have a healthy cash balance and potentially more coming in the door, as it closes asset sales that were first agreed to last year. It looks to be healthy, at least for now. But there’s also little doubt a leaner balance sheet would help.

It’s never a good sign when investors start to speculate a company would be better off in bankruptcy. If the action makes sense, then it’s usually only a matter of time.

How about a short-term flip?

While I’d never recommend investors buy a stock for the short term, there could very well be some upside potential for Bombardier shares over the near term.

Shares are down approximately 70% over the last two months, falling from a peak of more than $1.60 each on the Toronto Stock Exchange back on February 13. With that kind of bearish sentiment, it’s likely that any good news will send shares higher over the short term.

There’s also upside potential from short covering. Many investors are betting on Bombardier’s bankruptcy by selling shares short. To complete the trade, they’ll need to buy back in to cover their positions. This may cause temporary price hikes as these short-sellers drive the stock higher.

Still, betting on such things happening is risky business. I would recommend investors stay far away from that type of speculation.

The bottom line

Nobody knows for sure that Bombardier will go bankrupt, but it sure looks to me like that’s the only logical conclusion.

Even with the company potentially avoiding that fate, Bombardier is still a sell. There are still too many excellent stocks for investors to worry about weaker companies like Bombardier. Choose one of them rather than speculating on this investment.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »